Chicago / Edinburgh
THE IPOX® NEWSLETTERS

The IPOX® Update archive

Our weekly summary of news and developments across global IPO markets.

248 editions

The IPOX® Update 7/17/23

Israeli beauty tech firm Oddity Tech raises its IPO price range, eyeing a $357 million valuation. In Indonesia, PT Nusantara Sejahtera Raya, the largest cinema chain operator, successfully raised $150 million in an IPO, breaking a streak of high-priced Jakarta IPOs. State palm oil planter PalmCo and oil & gas company Pertamina Hulu Energi prepare for their IPOs, bolstering Indonesia's public markets. Meanwhile, inflammation-focused pharma firm MoonLake Immunotherapeutics is exploring a potential sale, causing its shares to surge.

Read edition

The IPOX® Update 7/14/23

General Atlantic, Goldman Sachs Asset Management, Kahoot’s CEO, and Kirkbi Invest propose a $1.7 billion buyout of Norwegian ed-tech company Kahoot! ASA, supported by investors who hold 34% of Kahoot's shares. In other news, Chinese agribusiness firm Syngenta is seeking Middle Eastern sovereign funds for its $9 billion Shanghai IPO. Simultaneously, car manufacturer Nissan is investing ¥100 billion in Renault's electric vehicle venture, Ampere.

Read edition

The IPOX® Update 7/13/23

Multiple global companies, including Brazil's JBS, Restaurant Brands Iberia, Wisekey International, Liquid Death, Lemon Sky Studios, and Healthy Green Group, have announced plans for their respective IPOs.

Read edition

The IPOX® Update 7/12/23

SoftBank-backed Arm Ltd. discusses IPO with Nvidia; Romanian Hidroelectrica debuts on Bucharest Stock Exchange; AXA mulls over private sale or IPO for XL Re; Tryt Inc. prices Tokyo IPO at 1,200 yen per share; Star Plus Legend Holdings' IPO oversubscribed 13 times; Oklo goes public via SPAC merger; Toronto Stock Exchange experiences IPO slump; Maggioli SpA withdraws IPO due to unsatisfactory market conditions.

Read edition

The IPOX® Update 7/11/23

Surf Air Mobility is set to trade on NYSE following a merger with Southern Airways. Biotech firm Apogee Therapeutics plans a $250 million IPO. Sagimet Biosciences files for an IPO in the NASH field. Oddity Tech files for an IPO on Nasdaq. Marti Technologies begins trading on NYSE. China's largest online fitness platform, Keep, is set to list in Hong Kong. Seed producer Syngenta plans a $9 billion IPO in Shanghai. Genesis MedTech weighs a potential $500m IPO in Hong Kong. Taiwan's stock exchange expects a surge in IPO applications.

Read edition

The IPOX® Update 7/10/23

German firm Intilion postpones IPO, Apogee Therapeutics targets $774.5m in its IPO, Bayer's shares increase on potential spinoff news, WuXi XDC Cayman files for a Hong Kong IPO, and Autozi Internet Technology seeks a $29m US IPO.

Read edition

The IPOX® Update 7/7/23

The global IPO market shows signs of recovery with successful offerings from various sectors. Hydrogen producer Nucera, Romanian hydropower firm Hidroelectrica, Birkenstock, and more are making headlines with their recent and upcoming IPOs, signaling renewed investor confidence.

Read edition

The IPOX® Update 7/6/23

Recent IPO news highlights include Japan's soaring IPO market, Thyssenkrupp's hydrogen unit Nucera's €2.5 billion IPO, Hidroelectrica's $10.28 billion IPO, PT Amman Mineral Internasional's largest Indonesian IPO this year, Keep Inc.'s $40 million Hong Kong IPO, Lu DaoPei Medical's Hong Kong IPO filing, Zhejiang Yongtai Technology's $107 million London GDR offering, and Claire's postponed public offering.

Read edition

The IPOX® Update 7/5/23

Fondul Proprietatea raises record $1.8B in Hidroelectrica's IPO, marking a milestone in Romania's equity market. ThyssenKrupp's hydrogen subsidiary, Nucera, announces IPO. Greece plans Athens International Airport's IPO. Investcorp prepares for IPO, as does Chinese retail giant, Shein. Meanwhile, some Middle Eastern companies delay IPOs, and London Stock Exchange modifies standards for Chinese listings.

Read edition
THE IPOX® NEWSLETTERS

Stay ahead of the next listing.

Research and insight from the global new listings market.

Explore our newsletters